FOREBRAIN NEUROTROPIC ABNORMALITIES & MILD COGNITIVE IMPAIRMENT IN THE ELDERLY
前脑神经营养异常
基本信息
- 批准号:6098740
- 负责人:
- 金额:$ 17.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-04-01 至 2000-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Although older (>65 years) individuals manifest cognitive impairments
ranging from mild abnormalities to overt dementia, the molecular and
cellular substrates that account for this variation remain to be defined.
Several reports indicate cholinergic hypofunction in elderly humans.
However, none of these studies related cholinergic changes to cognitive
status. The importance of this system to human cognition is
underscored by studies in Alzheimer's disease (AD) where the most
consistent neurochemical abnormality to crrelate with cognitive
impairment is decreases in cortical choline acetyltransferase (ChAT).
Interestingly, AD patients with an increased gene dose for the
apolipoprotein (ApoE) e4 allele (a genetic risk factor for AD) exhibit
greater cholinergic deficts (i.e., cortical ChAT reduction and
cholinergic basal forebrain(CBF) neuron loss) and are less responsive
to anticholinesterase drugs. The status of the CBF system and the
association of the ApoE genotype in aged individuals with mild
cognitive impairment (MCI), however, is still unknown. We do know,
however, that cortical ChAT levels decrease with aging in the human
brain. Therefore, Specific Aim 1 will establish whether CBF
degneration including reduction in cortical ChAT is associated with
cognitive impairment in individuals with MCI. Findings from our
group, have led to the hypothesis that the vulnerability of CBF
neurons results from defects in the binding or transport of NGF and
its high affinity signal transducing trkA receptor which, in turn, leads to
impaired NGF trophic support in AD. Support for this suggestion is
derived from our studies demonstrating that NGF protein-
immunoreactivity and the message for its high affinity trkA receptors
are decreased within CBF neurons whereas, cortical NGF protein is
increased in AD. Taken together these observations suggest that the
NGF protein accumulates within the cortex, because it is not
transported in a normal fashion to CBF consumer perikarya where it is
needed for its trophic effects to occur. Specific Aims 2-3 will
determine whether impaired NGF transport is also associated with
age-related MCI in the elderly. These studies will employ modern
stereology, bioassay, immunohistochemistry and in situ hybridization
procedures. The results of these investigations will have major
implications for therapeutic strategies in aging and MCI and the role
of genetics in considering these issues.
尽管年龄较大(65岁)的人表现出认知障碍
从轻微的异常到明显的痴呆,分子和
解释这种变异的细胞底物仍有待定义。
一些报告表明,老年人的胆碱能功能低下。
然而,这些研究中没有一项与胆碱能变化与认知有关。
状态。这个系统对人类认知的重要性是
阿尔茨海默病(AD)的研究强调了这一点,在那里
持续的神经化学异常与认知能力有关
损害是皮质胆碱乙酰转移酶(ChAT)的减少。
有趣的是,AD患者的基因剂量增加
载脂蛋白(ApoE)e4等位基因(AD的遗传危险因素)
更大的胆碱能缺陷(即皮质ChAT减少和
胆碱能基底前脑(CBF)神经元丢失),反应较差
到抗胆碱酯酶药物。CBF系统的现状和
老年轻症患者载脂蛋白E基因多态性的相关性研究
然而,认知障碍(MCI)仍不清楚。我们确实知道,
然而,人类大脑皮质聊天水平随着年龄的增长而降低
大脑。因此,具体目标1将确定CBF是否
包括皮质聊天减少在内的认知障碍与
MCI患者的认知功能障碍。来自我们的调查结果
导致了CBF的脆弱性的假说
神经元是由于NGF结合或运输存在缺陷而产生的
它的高亲和力信号转导TrkA受体,进而导致
AD患者NGF营养支持受损。对这一建议的支持是
来源于我们的研究表明,NGF蛋白-
免疫反应性及其高亲和力TrkA受体的信息
在CBF神经元内减少,而皮质NGF蛋白
在AD中增加。综上所述,这些观察表明
NGF蛋白在皮质内积聚,因为它不是
以正常方式运送到CBF消费者佩尔卡里亚
需要它的营养作用才能发生。具体目标2-3将
确定NGF转运受损是否也与
老年人的年龄相关性MCI。这些研究将使用现代化的
体视学、生物测定、免疫组织化学和原位杂交
程序。这些调查的结果将有重大的
老龄化和MCI治疗策略的意义及其作用
遗传学在考虑这些问题时的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ELLIOTT Jay MUFSON其他文献
ELLIOTT Jay MUFSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ELLIOTT Jay MUFSON', 18)}}的其他基金
Default mode network dysfunction in Down Syndrome
唐氏综合症的默认模式网络功能障碍
- 批准号:
10635582 - 财政年份:2023
- 资助金额:
$ 17.62万 - 项目类别:
FOREBRAIN NEUROTROPIC ABNORMALITIES & MILD COGNITIVE IMPAIRMENT IN THE ELDERLY
前脑神经营养异常
- 批准号:
6299385 - 财政年份:2000
- 资助金额:
$ 17.62万 - 项目类别:
GALANIN REMODELING IN THE PROGRESSION OF ALZHEIMER'S DISEASE
阿尔茨海默病进展中的甘丙肽重塑
- 批准号:
6299298 - 财政年份:2000
- 资助金额:
$ 17.62万 - 项目类别:
GALANIN REMODELING IN THE PROGRESSION OF ALZHEIMER'S DISEASE
阿尔茨海默病进展中的甘丙肽重塑
- 批准号:
6098278 - 财政年份:1999
- 资助金额:
$ 17.62万 - 项目类别:
Basic Neuroscience Training in Age-Related Disorders
年龄相关疾病的基础神经科学培训
- 批准号:
8451416 - 财政年份:1999
- 资助金额:
$ 17.62万 - 项目类别:
Basic Neuroscience Training in Age-Related Disorders
年龄相关疾病的基础神经科学培训
- 批准号:
8874078 - 财政年份:1999
- 资助金额:
$ 17.62万 - 项目类别:
Basic Neuroscience Training in Age-Related Disorders
年龄相关疾病的基础神经科学培训
- 批准号:
8658784 - 财政年份:1999
- 资助金额:
$ 17.62万 - 项目类别:
GALANIN REMODELING IN THE PROGRESSION OF ALZHEIMER'S DISEASE
阿尔茨海默病进展中的甘丙肽重塑
- 批准号:
6295529 - 财政年份:1999
- 资助金额:
$ 17.62万 - 项目类别:
FOREBRAIN NEUROTROPIC ABNORMALITIES & MILD COGNITIVE IMPAIRMENT IN THE ELDERLY
前脑神经营养异常
- 批准号:
6267724 - 财政年份:1998
- 资助金额:
$ 17.62万 - 项目类别:
相似国自然基金
ITS-HPLC-HRMS-Bioassay多级筛选策略指导下海洋真菌中新型抗菌活性产物的发现
- 批准号:41606166
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of advanced bioassay analysis system for internal dose assessment
开发用于内部剂量评估的先进生物测定分析系统
- 批准号:
23H03142 - 财政年份:2023
- 资助金额:
$ 17.62万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
This service is for The BPN Biologics program requires bioassay development expertise in order to support active cooperative agreements for drug development and discovery.
该服务适用于 BPN Biologics 计划需要生物测定开发专业知识,以支持药物开发和发现的积极合作协议。
- 批准号:
10949343 - 财政年份:2023
- 资助金额:
$ 17.62万 - 项目类别:
Development of a three-dimensional microkidney model and its disease model for bioassay
用于生物测定的三维微肾脏模型及其疾病模型的开发
- 批准号:
23H01983 - 财政年份:2023
- 资助金额:
$ 17.62万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a qualified pharmacokinetic bioassay to support preclinical and clinical studies of MM-008, a non-hormonal contraceptive antibody
开发合格的药代动力学生物测定法以支持非激素避孕抗体 MM-008 的临床前和临床研究
- 批准号:
10459074 - 财政年份:2022
- 资助金额:
$ 17.62万 - 项目类别:
Development of rapid and sensitive bioassay methods to contribute to actinide internal exposure medical response
开发快速、灵敏的生物测定方法,有助于锕系元素内照射医疗反应
- 批准号:
22K12384 - 财政年份:2022
- 资助金额:
$ 17.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of simple bioassay for detection of environmental trace contaminants and demonstration in Asian countries
开发用于检测环境痕量污染物的简单生物测定法并在亚洲国家进行示范
- 批准号:
21H01577 - 财政年份:2021
- 资助金额:
$ 17.62万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
L2M Market Assessment Grant: a bioassay to predict birth timing.
L2M 市场评估补助金:预测出生时间的生物测定。
- 批准号:
571251-2022 - 财政年份:2021
- 资助金额:
$ 17.62万 - 项目类别:
Idea to Innovation














{{item.name}}会员




